PreveCeutical Medical Inc. (OTCMKTS:PRVCF – Get Rating) was the recipient of a significant growth in short interest in July. As of July 15th, there was short interest totalling 3,800 shares, a growth of 850.0% from the June 30th total of 400 shares. Based on an average daily trading volume, of 75,600 shares, the short-interest ratio is presently 0.1 days.
PreveCeutical Medical Stock Performance
OTCMKTS PRVCF traded down $0.00 during mid-day trading on Friday, reaching $0.02. 10,257 shares of the stock were exchanged, compared to its average volume of 74,034. The business's 50 day moving average is $0.02 and its 200-day moving average is $0.02. PreveCeutical Medical has a 1 year low of $0.01 and a 1 year high of $0.03.
Get PreveCeutical Medical alerts:About PreveCeutical Medical
(Get Rating)
PreveCeutical Medical Inc, a health sciences company, engages in the development of options for preventive and curative therapies utilizing organic and nature identical products. Its pipeline products include Cannabinoid Sol-Gel Delivery, a cannabinoid-based nose-to-brain delivery system that provides relief from various indications, including pain, inflammation, seizures, and neurological disorders; BSV Peptide Program for targeting cancer progression; Non-Addictive Analgesic for pain management; and Dual Gene Therapy for type 2 diabetes and obesity.Further Reading
- Get a free copy of the StockNews.com research report on PreveCeutical Medical (PRVCF)
- Windfall Profits Have Exxon Mobil On Track For New Highs
- Adobe Stock, Why some investors are bullish, and others are not
- Was The Market Wrong On Etsy Again, As Shares Gain Post Earnings?
- Is Google The Buy Of The Summer?
- Should CVS Health Be in Your Portfolio?
Receive News & Ratings for PreveCeutical Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PreveCeutical Medical and related companies with MarketBeat.com's FREE daily email newsletter.